Last reviewed · How we verify
Ankle OnQ
Ankle OnQ is a continuous peripheral nerve block catheter system that delivers local anesthetic directly to nerve tissue around the ankle to provide prolonged postoperative pain relief.
Ankle OnQ is a continuous peripheral nerve block catheter system that delivers local anesthetic directly to nerve tissue around the ankle to provide prolonged postoperative pain relief. Used for Postoperative pain management following ankle surgery.
At a glance
| Generic name | Ankle OnQ |
|---|---|
| Sponsor | NYU Langone Health |
| Drug class | Peripheral nerve block catheter system with local anesthetic infusion |
| Modality | Small molecule |
| Therapeutic area | Pain Management / Orthopedic Surgery |
| Phase | FDA-approved |
Mechanism of action
The system consists of a small catheter placed near peripheral nerves in the ankle region, connected to a disposable elastomeric pump that continuously infuses local anesthetic (typically liposomal bupivacaine) over several days. This provides sustained regional anesthesia and analgesia without systemic opioid exposure, reducing pain and potentially improving recovery outcomes after ankle surgery.
Approved indications
- Postoperative pain management following ankle surgery
Common side effects
- Catheter-related complications (migration, kinking, dislodgement)
- Local anesthetic toxicity
- Infection at catheter site
- Nerve injury
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ankle OnQ CI brief — competitive landscape report
- Ankle OnQ updates RSS · CI watch RSS
- NYU Langone Health portfolio CI